Tianjin Chase Sun Pharmaceutical Co.,Ltd Stock Price

SZSE:300026 Community·CN¥9.8b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create Narrative

300026 Share Price Performance

CN¥3.26

-0.79 (-19.51%)

CN¥3.26

-0.79 (-19.51%)

CN¥3.26

Sun, 31 May 26

Share Pricen/a

300026 Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with acceptable track record.

2 Risks

1 Reward

View Full Analysis

Tianjin Chase Sun Pharmaceutical Co.,Ltd Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: 0.0079
: 57.14%
: 0.51%
: 4.8%

View Full Analysis

About 300026

Founded: 1996
Employees: 4852
CEO: Wu Jun Lan
WebsiteView website: www.chasesun.cn

Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves the fields of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases. The company was founded in 1996 and is headquartered in Tianjin, China.